Contact Information
Department of Medicine
Servei de Bioquímica i Genètica Molecular. Hospital Clínic de Barcelona. Villarroel 170. Barcelona 932275400 jto(a)ub.edu
Teaching imparted (current)
Toxicologia -
Ciencias Biomédicas -
Universidad de Barcelona.
Medicina Legal i Toxicologia. Deontologia i Legislació Mèdica -
Medicina -
Universidad de Barcelona.
Academic training
Biologia
. Universitat de Barcelona
. 01/07/1979
. (Diploma / Degree / Activities)Biologia
. Universitat de Barcelona
. 1984
. (Ph.D.)
Professional experience
Consultor senior del Servei de Bioquímica i Genètica Molecular.
Hospital Clinic de Barcelona.
01/01/2008
Research interests
Diagnòstic i fisiopatologia de les porfíries
Research Projects
European Porphyria Network: providing better healthcare for patients and their families (EPNET). Work Package 6:Network of laboratory centres for porphyria diagnosis
.
2008 - 2013
. Ref.800108
. Public Heatlh Executive Agency
. PI: Jean-Charles DeybachEstudio metabolómico en pacientes con Porfiria Aguda Intermitente: caracterización de los desajustes hormonales y catabólicos asociados a la enfermedad y efectos del tratamiento con hemina
.
2014 - 2018
. Ref.PI14/00147
. Fondo de Investigación Sanitaria. Instituto de Salud Carlos III
. PI: Oscar Pozo; Jordi To-Figueras
Journal Publications
Combalia, A.; To-Figueras, J.; Laguno, M.; Martinez-Rebollar, M.; Aguilera, P.(2017).
Direct-acting antivirals for hepatitis C virus induce a rapid clinical and biochemical remission of porphyria cutanea tarda.British Journal of Dermatology, 177(5), pp. e183 - e184
. Institutional Repository. ISSN: 0007-0963Gomez-Gomez, A; Marcos, J; Aguiler,a P; To-Figueras, J; Pozo, OJ.(2017).
Comprehensive analysis of the tryptophan metabolome in urine of patients with acute intermittent porphyria.Journal Of Chromatography B-Analytical Technologies In The Biomedical And Life Sciences, 1060, pp. 347 - 354
. https://www.ncbi.nlm.nih.gov/pubmed/28666226. ISSN: 1570-0232To-Figueras, J.(2019).
Association between hepatitis C virus and porphyria cutanea tarda.Molecular Genetics and Metabolism, 3(128), pp. 282 - 287
. https://doi.org/10.1038/s41436-019-0537-7. ISSN: 1096-7192Sastre L, To-Figueras J, Lens S, Rodríguez-Tajes S, Zartres C, Aguilera P, Badenas C, Oliva R, Pocurull A, Forns X, Mariño Z(2020).
Resolution of subclinical porphyria cutanea tarda after hepatitis C eradication with direct acting antivirals.Alimentary Pharmacology & Therapeutics, 51, pp. 968 - 973
. https://doi.org/10.1111/apt.15703. ISSN: 0269-2813To-Figueras J; Wijngaard R; García-Villoria J; Aarsand AK; Aguilera P; Deulofeu R; Brunet M; Gómez-Gómez À; Pozo OJ; Sandberg S-(2021).
Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran.Journal of Inherited Metabolic Disease, 44(4), pp. 961 - 971
. https://doi.org/10.1002/jimd.12391. ISSN: 0141-8955
Other publications
Casals, G.; To-Figueras, J.(2019).
Epidemias y catástrofes tóxicas
. In
Toxicologia Clínica (Editor Santiago Nogué Xarau)
. (pp. 23 - 29)
. Elsevier
. ISBN: 978-84-9113-340-7
.
Relevant activities
Membre de EPNET (European Porphyria Network)()
. 01/01/2000